Evidence map›Paper›PMID 27571972›Full record

ArticleNature microbiology2016

Activation of band 3 mediates group A Streptococcus streptolysin S-based beta-haemolysis.

Dustin L Higashi, Nicolas Biais, Deborah L Donahue, Jeffrey A Mayfield, Charles R Tessier, Kevin Rodriguez, Brandon L Ashfeld, Jeffrey Luchetti, Victoria A Ploplis, Francis J Castellino and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Group aMicrobiology spectrum · 2025
    Article
  4. Review
  5. Enterolyin S, a Polythiazole-containing Hemolytic Peptide from Enterococcus caccae.Chembiochem : a European journal of chemical biology · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Streptococcal peptides and their roles in host-microbe interactions.Frontiers in cellular and infection microbiology · 2023
    Review
  11. Review
  12. Article
  13. Listeriolysin S: A bacteriocin fromProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Pathogens (Basel, Switzerland) · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Dustin L HigashiDepartment of Biological Sciences, University of Notre Dame, 100 Galvin Life Sciences Center, Notre Dame, Indiana 46556, USA.
Nicolas BiaisBiology Department, Brooklyn College CUNY, New York 11210, USA.
Deborah L DonahueW.M. Keck Center for Transgene Research, University of Notre Dame, Notre Dame, Indiana 46556, USA.
Jeffrey A MayfieldW.M. Keck Center for Transgene Research, University of Notre Dame, Notre Dame, Indiana 46556, USA.
Charles R TessierIndiana University School of Medicine, South Bend, Indiana 46617, USA.
Kevin RodriguezDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.
Brandon L AshfeldDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.
Jeffrey LuchettiDepartment of Biological Sciences, University of Notre Dame, 100 Galvin Life Sciences Center, Notre Dame, Indiana 46556, USA.
Victoria A PloplisW.M. Keck Center for Transgene Research, University of Notre Dame, Notre Dame, Indiana 46556, USA.
Francis J CastellinoW.M. Keck Center for Transgene Research, University of Notre Dame, Notre Dame, Indiana 46556, USA.
Shaun W LeeDepartment of Biological Sciences, University of Notre Dame, 100 Galvin Life Sciences Center, Notre Dame, Indiana 46556, USA.
University of Notre Dame · USBrooklyn College · USIndiana University School of Medicine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus pyogenes, or group A Streptococcus (GAS), is a human bacterial pathogen that can manifest as a range of diseases from pharyngitis and impetigo to severe outcomes such as necrotizing fasciitis and toxic shock syndrome. GAS disease remains a global health burden with cases estimated at over 700 million annually and over half a million deaths due to severe infections(1). For over 100 years, a clinical hallmark of diagnosis has been the appearance of complete (beta) haemolysis when grown in the presence of blood. This activity is due to the production of a small peptide toxin by GAS known as streptolysin S. Although it has been widely held that streptolysin S exerts its lytic activity through membrane disruption, its exact mode of action has remained unknown. Here, we show, using high-resolution live cell imaging, that streptolysin S induces a dramatic osmotic change in red blood cells, leading to cell lysis. This osmotic change was characterized by the rapid influx of Cl(-) ions into the red blood cells through SLS-mediated disruption of the major erythrocyte anion exchange protein, band 3. Chemical inhibition of band 3 function significantly reduced the haemolytic activity of streptolysin S, and dramatically reduced the pathology in an in vivo skin model of GAS infection. These results provide key insights into the mechanism of streptolysin S-mediated haemolysis and have implications for the development of treatments against GAS.

Indexed as

HemolysisAnimalsAnion Exchange Protein 1, ErythrocyteBacterial ProteinsDisease Models, AnimalErythrocytesHumansIntravital MicroscopyMiceSheepSkin Diseases, BacterialStreptococcal InfectionsStreptococcus pyogenesStreptolysinsAnion Exchange Protein 1, ErythrocyteBacterial Proteinsstreptolysin SStreptolysins

Identifiers

PMID27571972
OpenAlexW2508614063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.